Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    9118708 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Clinical Trials to Reduce the Risk of Antimicrobial Resistance
Condition: Bacterial Pneumonia
Interventions: Drug: IV meropenem;   Drug: I.V. Meropenem;   Drug: Parenteral aminoglycoside; tobramycin for injection USP OR gentamicin sulfate injection solution concentrate IV q24h; amikacin sulfate injection USP 20 mg/kg IV q24h;   Drug: Linezolid or Vancomcin (per institutional guidelines) will be available for MRSA coverage.;   Device: tobramycin nebulization

Study has passed its completion date and status has not been verified in more than two years.